glp-1pricelist

The transparent cost desk
Independent editorial information · not individual medical advice

Commercial pages may contain paid referral links. Compare the full payment terms and licensed-care details before enrollment.

Affiliate Disclosure: We earn commissions from qualifying purchases. This does not influence our editorial coverage. Learn more
🔮 Pipeline📅 July 2026 · ⏱️ 11 min read

Orforglipron Pricing Signals: Why an Oral Pill Could Reset the Market

Price verification — October 26, 2026

This article includes an older pricing snapshot. Older amounts, coupons and annual totals below are historical illustrations, not current checkout quotes.

  • Foundayo (orforglipron, oral): LillyDirect self-pay starts at $149/30 days for 0.8 mg and, temporarily through Dec. 31, 2026, for 2.5 mg; 5.5 mg is temporarily $199, 9 mg is $299, and 14.5/17.2 mg generally $349 (a conditional $299 refill offer may apply). Other doses have different prices. Official source
  • Clinical program fees: Ivím lists a $74.99/month membership with medication billed separately. Sesame lists care from $59/month on a 12-month commitment; month-to-month costs more, and medication is separate. These are care fees, not all-inclusive drug prices. Official source
  • Sesame annual-commitment terms: Official source.

These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due. Compounded GLP-1 products are not FDA-approved. Their availability, lawful compounding circumstances and product claims require separate verification. FDA policy.

Foundayo — the first non-peptide, oral-only GLP-1 — is now FDA-approved. Its pricing strategy could reshape the entire compounded market.

Why Foundayo Matters

Orforglipron, marketed as Foundayo by Novo Nordisk, represents a fundamentally different kind of GLP-1 medication. Unlike semaglutide and tirzepatide — which are peptide-based molecules that must be injected or carefully formulated for oral absorption — orforglipron is a small-molecule, non-peptide compound designed from the ground up for oral bioavailability.

This distinction matters enormously for pricing. Small-molecule drugs are dramatically cheaper to manufacture than peptides. They do not require sterile compounding, cold-chain shipping, or injection supplies. They are pills. And pills scale.

Oral pill
Daily administration
Non-peptide
Cheaper to manufacture
$149–$299
NovoCare pricing

Current Foundayo Pricing

Historical price illustration from this article; not a verified October 2026 provider quote. Check the official pricing sources above.
ChannelMonthly PriceNotes
NovoCare self-pay (low dose)~$149/moStarting doses
NovoCare self-pay (maintenance)~$299/moHigher doses
Medicare Bridge$50/moEligible beneficiaries
Commercial insurance (with savings card)~$25/moIf plan covers weight loss
Retail (no discounts)~$1,349/moList price

At $149/month for starting doses, Foundayo is the cheapest FDA-approved GLP-1 option available — and it is a pill. No needles, no vials, no syringes, no cold shipping. The simplicity is the disruption.

💡 Foundayo at $149/month undercuts every injectable brand-name program and competes directly with mid-tier compounded providers. For the first time, patients can access an FDA-approved, brand-name GLP-1 oral medication at a price point that overlaps with compounded alternatives.

How Foundayo Disrupts the Compounded Market

The Challenge for Compounders

Compounded semaglutide's primary value proposition has always been: "same active ingredient, much cheaper than brand-name." Foundayo disrupts this narrative in two ways:

Where Compounded Still Wins

Sponsored partner · Compounded and branded pathwaysGobyMeds

Explore the program’s treatment pathways and ask which medication type, pharmacy, enrollment requirements and recurring charges apply to your location.

Explore GobyMeds ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.

Sponsored · Compounded medications are not FDA-approved.

Sponsored partner · current offerGobyMeds

Explore available weight-management program types and confirm the exact medication, pharmacy and recurring charges.

Explore GobyMeds ↗Medication, legal availability, provider credentials and full price require verification; compounded medications are not FDA-approved.

Sponsored · Compounded medications are not FDA-approved.

The Manufacturing Cost Advantage

Orforglipron's small-molecule structure means manufacturing costs are a fraction of peptide-based GLP-1s:

FactorPeptide GLP-1 (semaglutide)Small Molecule (orforglipron)
Manufacturing complexityHigh (recombinant or synthetic peptide)Low (standard chemical synthesis)
Estimated COGS/month$0.89–$4.73Likely lower
Cold chain requiredYes (injectable)No (oral tablet)
Supply kit neededSyringes, alcohol swabs, sharpsNone
Shipping costHigher (temperature-controlled)Lower (standard mail)
ScalabilityLimited by sterile manufacturingHigh (pill production at scale)

These cost advantages give Novo Nordisk room to price Foundayo aggressively while maintaining strong margins — and potentially cut prices further as production scales. The floor for Foundayo pricing is much lower than the floor for injectable brands.

Who Should Consider Foundayo

Sponsored partner · Consultation and accessSesame Care

Review consultation options, program fees, medication access, insurance considerations and what happens after your first appointment.

Explore Sesame Care ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.

Sponsored · FDA-approved medications prescribed through licensed clinicians.

Sesame Care prescribes FDA-approved brand-name medications, including Foundayo, for patients who prefer the oral format with full regulatory backing.

Who Should Stick With Compounded

Sponsored partner · Weight-management telehealthGala GLP-1

Review program enrollment, whether medication is compounded, dispensing pharmacy information, and the total ongoing price.

Explore Gala GLP-1 ↗Eligibility and prices must be verified directly. Compounded GLP-1 products are not FDA-approved.

Sponsored · Compounded medications are not FDA-approved.

Sponsored partner · current offerHealthRX — semaglutide

A listing for compounded semaglutide. Compounded medication is not FDA-approved; verify current lawful availability.

Explore HealthRX — semaglutide ↗Medication, legal availability, provider credentials and full price require verification; compounded medications are not FDA-approved.

Sponsored · Compounded medications are not FDA-approved.

The Market Reset Scenario

Here is the scenario that keeps compounding pharmacies up at night: Novo Nordisk drops Foundayo's self-pay price to $99/month to match the compounded floor. At that price, with FDA approval, the value proposition of compounded semaglutide collapses for most patients. The compounded market would shrink to niche use cases only.

Is this likely? Not immediately. Novo Nordisk's margin structure and pharmaceutical pricing norms make a $99 brand-name price unlikely in the near term. But if generic semaglutide arrives in 2031–2034 at $50–$100/month, and Foundayo is already at $149, Novo may cut further to defend market share. The long-term trajectory points toward convergence between brand, generic, and compounded pricing.

The Bottom Line

Foundayo is the most significant pricing disruptor in the GLP-1 market since compounded semaglutide entered the scene. At $149/month starting dose, it is the first FDA-approved GLP-1 that directly competes with mid-tier compounded providers on price. For budget-conscious patients at $99/month compounded providers, the math still favors compounded. For everyone else — especially needle-averse patients and those who value FDA approval — Foundayo is worth serious consideration.

⚠️ Foundayo (orforglipron) is FDA-approved. Compounded GLP-1 medications are not FDA-approved. Orforglipron is a different molecule than semaglutide or tirzepatide. Consult your clinician about which medication and format is appropriate for your clinical situation.

See today's live prices

Compare 20+ verified GLP-1 providers in one place — updated daily.

View Price Comparison →

📬 The GLP-1 Cost & Provider Comparison Guide

10 pages breaking down real all-in monthly costs, what drives price differences between providers, and the questions to ask before you commit.